ADMP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 sep 2023 @ 21:59):

Stats
Dagens volum	119 482
Gjennomsnittsvolum	3.11M
Markedsverdi	7.25M
EPS	$0.0493 ( Q3 \| 2023-11-14 )
Neste inntjeningsdato	( $0 ) 2024-08-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0764 (Sector) 42.63 (Industry) 0
ATR14	$0.190 (30.44%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -3.46%

ALIM -0.63%

AMPH -3.58%

AMYT 0.00%

ANIP -0.60%

AQST -7.12%

ASRT 0.00%

ATNX 0.00%

AVDL -1.81%

AYTU -4.12%

BFRI -2.00%

BGXX 6.95%

CLVR -1.89%

COLL 1.02%

CPIX -3.18%

CRDL -1.24%

CRON -1.72%

CYTH -3.40%

DCPH 0.00%

DERM -3.37%

DRRX 0.53%

DVAX -0.49%

EGRX -3.57%

EMBC -2.20%

EMBCV -9.33%

EOLS 1.47%

ESPR 5.41%

EVOK -4.54%

FLGC -3.19%

FLXN 0.00%

GHSI -1.68%

HCM 2.98%

HROW 1.53%

HUGE -5.99%

IMCC -3.78%

INCR 1.74%

IRWD 1.07%

ITCI -2.71%

IXHL 0.34%

JUPW 11.76%

KALA -1.12%

KIN 0.11%

KMDA -1.20%

LNTH -0.72%

NBIX 1.53%

NEPT 0.00%

NLTX 1.45%

OGI 0.32%

OPTN 2.42%

ORGO -1.43%

PAHC 2.15%

PCRX 0.21%

PETQ 1.63%

PLXP 0.00%

PPD 0.00%

PROC 3.48%

PRPH -3.35%

PTPI -0.88%

RDHL -0.65%

RDUS 1.38%

REPH -0.48%

RGC -5.03%

RMTI -2.29%

SCTL 0.92%

SCYX -4.95%

SIGA -0.79%

SISI -15.00%

SNDL 0.53%

SNOA 8.34%

SSIC -2.79%

SUPN -0.11%

SXTC 0.00%

THTX -1.41%

TKNO -10.22%

TLGT -13.85%

TLRY 1.20%

TXMD 5.90%

TYHT -3.90%

UPC 3.75%

VTRS -0.19%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2023-10-23	Dorbin John W. Jr.	Buy	70 000	Employee Stock Option (right to buy)
2023-10-23	Dorbin John W. Jr.	Buy	0
2023-10-16	Cohen Seth	Buy	151 416	Employee Stock Option (right to buy)
2023-10-16	Cohen Seth	Buy	0
2023-09-15	Versi Ebrahim	Buy	729 200	Common Stock

INSIDER POWER
96.85
Last 88 transactions
Buy: 1 947 813 \| Sell: 1 308 563

Volum Korrelasjon

Lang: -0.04 (neutral)

Kort: -0.22 (neutral)

Signal:(43.501) Neutral

Adamis Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Adamis Pharmaceuticals Korrelasjon - Valuta/Råvare

0.60
( weak )

0.49
( neutral )

0.89
( strong )

0.17
( neutral )

-0.77
( moderate negative )

-0.33
( neutral )

Adamis Pharmaceuticals Økonomi

Annual	2022
Omsetning:	$4.76M
Bruttogevinst:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2022
Omsetning:	$4.76M
Bruttogevinst:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2021
Omsetning:	$2.21M
Bruttogevinst:	$-4.66M (-211.14 %)
EPS:	$-0.320

FY	2020
Omsetning:	$16.53M
Bruttogevinst:	$1.63M (9.88 %)
EPS:	$-0.640

Financial Reports:

No articles found.

Adamis Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.